Sera Prognostics (SERA) announced the pricing of its underwritten public offering of 1.25M shares of its Class A common stock at a public

The firm plans to use the proceeds to support commercial expansion in the US and EU, and for research, potential regulatory submissions, and general corporate purposes.

Sera Prognostics, a company specializing in high-value women's health diagnostics with a market capitalization of $134 million, has seen its stock price touch a 52-week low, trading at $3.84. According to InvestingPro data,

Sera Prognostics (SERA) announced that it has commenced a proposed underwritten public offering of its Class A common stock and, in lieu of

SALT LAKE CITY - Sera Prognostics, Inc. (SERA), a company specializing in pregnancy biomarker information, has initiated a public offering of its Class A common stock and pre-funded warrants. The offering includes an additional option for underwriters to purchase up to 15% more shares.